Newborn screening in Taiwan: Q&A with Dr Yin-Hsiu (Nancy) Chien

C.Yin-HsiuC.Yin-Hsiu
BulletArticle
Newborn Screening Rare Diseases
Chia sẻ điều này:
Sao chép liên kết
Newborn screening in Taiwan: Q&A with Dr Yin-Hsiu (Nancy) Chien

As Director of the Newborn Screening Centre at National Taiwan University Hospital, Dr Yin-Hsiu (Nancy) Chien is at the forefront of Taiwan’s newborn screening (NBS) efforts. In this Q&A, we speak with Dr Chien about how NBS works in Taiwan, drawing upon her experience as a clinician-researcher and lab director to explore key considerations around panel composition, sample collection, lab workflows, and hopes for the future of NBS.

Chia sẻ điều này:
Sao chép liên kết

Xem thêm về cùng chủ đề

Should newborn screening include chromosome 15q disorders?

How Early Check shapes newborn screening policy with better evidence

Chủ đề được đề xuất

SequencingRED 2020Rare Diseases
Đọc tiếp theo
  • C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
  • C-Suite Perspectives, Leaders In Conversation, Management
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top